Aventis/Genta Genasense meeting confirmed
Executive Summary
Date for review of Aventis/Genta's antisense drug Genasense by FDA's oncologic committee has been confirmed for May 3. Genta said it would receive an early May review by the committee (1"The Pink Sheet" Feb. 16, 2004, p. 6). The meeting will begin at 8 a.m. at the Hilton in Gaithersburg, Md...
|
Date for review of Aventis/Genta's antisense drug Genasense by FDA's oncologic committee has been confirmed for May 3. Genta said it would receive an early May review by the committee (1 (Also see "Aventis/Genta Genasense NDA Expected To Go Before ODAC In May" - Pink Sheet, 16 Feb, 2004.) p. 6). The meeting will begin at 8 a.m. at the Hilton in Gaithersburg, Md.... |